premargin

Element List	Explanation
Introduction	Jamjoom Pharmaceuticals Factory Company (the “Company”) is pleased to announce its Board of Directors’ decision to distribute interim cash dividends to shareholders for the second half of 2025, as per the details stated below.
Date of the board’s decision	2026-02-23 Corresponding to 1447-09-06
The Total amount distributed	140,000,000
Number of Shares Eligible for Dividends	70,000,000
Dividend per share	SAR 2.00
Percentage of Dividend to the Share Par Value (%)	20
Eligibility date	2026-03-01 Corresponding to 1447-09-12
Distribution Date	2026-03-15 Corresponding to 1447-09-26
The name of other official authorities and the details of their non-refusal to the recommendation or decision	NA
Additional Information	The Company would like to inform its Shareholders of the necessity of updating their data and ensure that their bank account numbers are linked to their investment portfolios to ensure that their cash dividends are deposited in their accounts with the banks on the distribution day. We would like to draw the attention of non-resident foreign investors to the fact that the cash distributions are transferred through the resident financial intermediary, and when transferred or credited in his account, are subject to a withholding tax of 5% in accordance with the provisions of Article (68) of the tax system and Article (63) of its implementing regulations. For any inquiries, please directly contact the Investor Relations Department through: IR@jamjoompharma.com

Jamjoom Pharmaceuticals Factory Co. announces the board of director’s decision to distribute cash dividends for Second half of 2025 (Six months)